Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/10/99 → 10/31/01 |
Funding
- Merck and Company: $20,548.00
STUDY TO EVALUATE THE EFFICACY, SAFETY,AND TOLERABILITY OF MK -0826 VS PIPERACILLIN/TAZOBACTAM IN THE TREATMENT OF ....
- Baker, David A. (PI)
- Salmieri, Stephen (CoPI)
Project: Research